AGNPF (Grey Matters Health) 5-Year EBITDA Growth Rate: 51.80% (As of May. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

AGNPF Grey Matters Health Inc AGNPF
26 GF Score
Price $0.37
! 1 Warning Sign
View Full Analysis

What is Grey Matters Health 5-Year EBITDA Growth Rate?

Grey Matters Health AGNPF -12.16% 26 5-Year EBITDA Growth Rate is 51.80% as of May. 2026. GuruFocus rates AGNPF with a GF Score™ of 26/100. The stock has 1 warning sign investors should review.

Grey Matters Health's EBITDA per Share for the three months ended in May. 2026 was $-0.09.

During the past 3 years, the average EBITDA Per Share Growth Rate was 59.70% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 51.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 11 years, the highest 3-Year average EBITDA Per Share Growth Rate of Grey Matters Health was 59.70% per year. The lowest was -24.10% per year. And the median was 36.40% per year.

Grey Matters Health  (OTCPK:AGNPF) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

Grey Matters Health 5-Year EBITDA Growth Rate Related Terms

AGNPF vs VRTX, REGN, MRNA: 5-Year EBITDA Growth Rate Comparison

For the Biotechnology subindustry, Grey Matters Health's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Grey Matters Health 5-Year EBITDA Growth Rate vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Grey Matters Health's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Grey Matters Health's 5-Year EBITDA Growth Rate falls into.


AGNPF
26GF Score
Grey Matters Health Inc AGNPF
5-Year EBITDA Growth Rate is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Grey Matters Health 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

What does a 5-Year EBITDA Growth Rate of 51.80% mean?
Grey Matters Health (AGNPF) has a 5-Year EBITDA Growth Rate of 51.80% as of May. 2026. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Grey Matters Health and its competitors.
Is Grey Matters Health's 5-Year EBITDA Growth Rate too high?
Grey Matters Health's current 5-Year EBITDA Growth Rate is 51.80%. Overall, Grey Matters Health has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Grey Matters Health's 5-Year EBITDA Growth Rate compare to VRTX and REGN?
Grey Matters Health's 5-Year EBITDA Growth Rate of 51.80% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year EBITDA Growth Rate for a Biotechnology company?
A good 5-Year EBITDA Growth Rate depends on the Biotechnology industry context. However, 5-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year EBITDA Growth Rate mean?
A high 5-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Grey Matters Health and its competitors. Grey Matters Health's current 5-Year EBITDA Growth Rate is 51.80%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Grey Matters Health stock overvalued right now?
Grey Matters Health (AGNPF) has a current 5-Year EBITDA Growth Rate of 51.80%. The current 5-Year EBITDA Growth Rate is 51.80%. Grey Matters Health's overall GF Score™ is 26/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year EBITDA Growth Rate calculated?
5-Year EBITDA Growth Rate is calculated from a company's financial statements. For Grey Matters Health (AGNPF), the current 5-Year EBITDA Growth Rate is 51.80% as of May. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Grey Matters Health Business Description

Other Exchanges GREY:Canada
Address 601 West Broadway, Suite 400, Vancouver, BC, CAN, V5Z 4C2
Grey Matters Health Inc is a drug repurposing company that investigates safe, already approved drugs for new disease applications, moving them efficiently and safely into new human trials, developing new formulations, and seeking new regulatory approvals in world-wide markets.
26GF Score

Get the complete analysis for AGNPF

5-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.37
Price